Bridgewater Associates’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,901
| Closed | -$410K | – | 899 |
|
|
2024
Q1 | $410K | Sell |
18,901
-2,911
| -13% | -$63.2K | ﹤0.01% | 639 |
|
|
2023
Q4 | $631K | Sell |
21,812
-2,751
| -11% | -$79.5K | ﹤0.01% | 684 |
|
|
2023
Q3 | $657K | Buy |
24,563
+2,402
| +11% | +$64.2K | ﹤0.01% | 665 |
|
|
2023
Q2 | $821K | Sell |
22,161
-1,223
| -5% | -$45.3K | 0.01% | 605 |
|
|
2023
Q1 | $730K | Buy |
23,384
+792
| +4% | +$24.7K | ﹤0.01% | 598 |
|
|
2022
Q4 | $673K | Sell |
22,592
-10,726
| -32% | -$319K | ﹤0.01% | 691 |
|
|
2022
Q3 | $1.27M | Buy |
33,318
+1,374
| +4% | +$52.4K | 0.01% | 653 |
|
|
2022
Q2 | $1.74M | Buy |
31,944
+3,006
| +10% | +$164K | 0.01% | 708 |
|
|
2022
Q1 | $1.81M | Buy |
28,938
+6,929
| +31% | +$432K | 0.01% | 704 |
|
|
2021
Q4 | $2.21M | Sell |
22,009
-5,761
| -21% | -$580K | 0.01% | 450 |
|
|
2021
Q3 | $2.5M | Sell |
27,770
-2,083
| -7% | -$187K | 0.01% | 404 |
|
|
2021
Q2 | $2.75M | Buy |
+29,853
| New | +$2.75M | 0.02% | 435 |
|